ARBITER: Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol: a randomized trial comparing the effects of atorvastatin and pravastatin on carotid intima medial thickness.
about
Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosisNew frontiers in obstructive sleep apnoeaNon-invasive vulnerable plaque imaging: how do we know that treatment works?Regression of atherosclerosis: insights from animal and clinical studiesNoninvasive Cardiovascular Risk Assessment of the Asymptomatic Diabetic Patient: The Imaging Council of the American College of CardiologyAnti-inflammatory and morphologic effects of pitavastatin on carotid arteries and thoracic aorta evaluated by integrated backscatter trans-esophageal ultrasound and PET/CT: a prospective randomized comparative study with pravastatin (EPICENTRE studyCommon carotid artery intima-media thickness is as good as carotid intima-media thickness of all carotid artery segments in improving prediction of coronary heart disease risk in the Atherosclerosis Risk in Communities (ARIC) studyDifferential impacts of blood pressure and lipid lowering on regression of ventricular and arterial mass: the Stop Atherosclerosis in Native Diabetics Trial.Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk: the ARIC (Atherosclerosis Risk In Communities) study.Carotid intima-media thickness studies: study design and data analysis.Effects of statins on progression of carotid atherosclerosis as measured by carotid intimal--medial thickness: a meta-analysis of randomized controlled trials.Submaximal exercise coronary artery flow increases in postmenopausal women without coronary artery disease after estrogen and atorvastatin.Management of cardiovascular complications in systemic lupus erythematosus.Effects of statins on progression of coronary artery disease as measured by intravascular ultrasound.Low high-density lipoprotein cholesterol: current status and future strategies for management.Effect of lower targets for blood pressure and LDL cholesterol on atherosclerosis in diabetes: the SANDS randomized trialManagement of carotid artery stenosis. Update for family physicians.Rosuvastatin and progression of atherosclerosis.Association of 10-year and lifetime predicted cardiovascular disease risk with subclinical atherosclerosis in South Asians: findings from the Mediators of Atherosclerosis in South Asians Living in America (MASALA) study.Aggressive very low-density lipoprotein (VLDL) and LDL lowering by gene transfer of the VLDL receptor combined with a low-fat diet regimen induces regression and reduces macrophage content in advanced atherosclerotic lesions in LDL receptor-deficienPotential nontraditional applications of statins.Carotid plaque regression following 6-month statin therapy assessed by 3T cardiovascular magnetic resonance: comparison with ultrasound intima media thicknessAssociations of carotid artery intima-media thickness (IMT) with risk factors and prevalent cardiovascular disease: comparison of mean common carotid artery IMT with maximum internal carotid artery IMT.Agents that stabilise atherosclerotic plaque.Influence of atorvastatin on coronary calcifications and myocardial perfusion defects in systemic lupus erythematosus patients: a prospective, randomized, double-masked, placebo-controlled studyThe Interleukin-6 inflammation pathway from cholesterol to aging--role of statins, bisphosphonates and plant polyphenols in aging and age-related diseasesCoronary event secondary prevention with statins irrespective of LDL-cholesterol.Intensive lipid-lowering therapy in patients with coronary heart disease.Intensive statin therapy in acute coronary syndromes and stable coronary heart disease: a comparative meta-analysis of randomised controlled trials.Torcetrapib/atorvastatin combination therapy.Management of hereditary dyslipidaemia; the paradigm of autosomal dominant hypercholesterolaemia.Effective management of dyslipidaemia among patients with cardiovascular risk: updated recommendations on identification and follow-up.Changes in carotid intima-media thickness during the cardiac cycle: the multi-ethnic study of atherosclerosis.Prospects for atherosclerosis regression through increase in high-density lipoprotein and other emerging therapeutic targetsStatins in stroke: prevention, protection and recovery.The role of statins in reversing atherosclerosis: what the latest regression studies show.PROVE-IT proved it: lower is better--pro.The efficacy and safety of intensive statin therapy: a meta-analysis of randomized trials.Application of intravascular ultrasound in anti-atherosclerotic drug development.Thematic review series: patient-oriented research. Imaging atherosclerosis: state of the art.
P2860
Q24634165-F87F7469-CC1A-4B4A-B9F7-8F868191543DQ26823972-5023FB24-4094-4203-BB08-E7FCC1303F39Q27020959-6CD1D3B4-99F6-4124-9D9A-82AA9E162BEFQ27028112-8E8DB695-A1CA-4E2B-BFB4-6FB600F7C80BQ30277401-FFDD5CC7-75E2-45A6-9CFE-A65AFD4167A2Q30414631-BD86BC06-3EA0-4CAE-B305-FF0B75F1D27FQ30459508-15C9F9B1-A80D-4244-A4FB-FAB294E8113CQ30464117-4F0BC855-6EBB-48F6-8AF7-A310E3DB8651Q30475835-DC6C9A78-97BA-4742-AF8D-392D69983BD5Q30712446-CA1FD37B-5F8F-4D74-99D3-21BD0A78F3D6Q33578968-2EAD7A17-E2BF-46F9-AFFC-87DC60E8C60DQ33590651-CD8214F2-38DC-44C0-9E79-68EB6C82D53DQ33730536-071FF993-818E-43CF-AECE-FEA55EED43D0Q33962454-58A963D6-E95A-4A30-B1D6-6ECA010DA760Q34334846-767FE899-D000-4C00-8A20-1C745D1DE4B3Q34571157-1ACFE149-0492-4F95-9400-DD780E2C54E7Q34682853-EEC2BEDF-022D-41E0-AA1B-ECE0BAD66E5AQ34802802-891F316B-599E-4727-8619-D552A4D69031Q35070743-129DA7DB-10B8-430A-A4A6-6728C84B6356Q35088381-63D66648-20D3-4DC2-941C-6F3F003BB91EQ35169445-CB2588E2-BDB8-44C1-B2E0-1F30F4CA0711Q35196130-2A98A2F6-19BB-460A-97E2-A3840058F901Q35264203-848DFBC3-7CBB-4CBD-9924-B364CB76167AQ35547296-547CEEFF-907A-4241-909F-5708AAC7B4ECQ35617640-7F2CBCFE-6EF7-4E71-A3E8-47D47A1C27D5Q35738921-C0DFF0CE-B353-4FB0-A194-78F0987BB072Q35762270-CE3FCE6F-FC45-4C01-9969-4BA8D93A865DQ35991019-6DDF6990-B29C-4772-B8AB-6E1075B3840FQ36014039-BF04DED8-78AF-4B98-BD63-8A1A5524C907Q36265996-C4B17AE4-D9A3-4869-A17C-D4BBBCBCDBEAQ36270428-25C59315-04B2-44EA-A93C-E9F4101D0B10Q36360311-48C0EDD6-5094-4D21-B18A-BF30093ECD2DQ36366248-6DB555B8-1EA1-424A-85EE-AEA4CB722445Q36383197-3B1E16EA-EE65-4F9F-9600-930E816F6F55Q36390817-3AC0FF6B-49AB-46D2-814E-6080458BB424Q36398720-9AD6E208-07FB-4496-B59C-4BEF8B8459D2Q36405162-9FACBDE2-FF7C-4C95-A321-570A6064B492Q36462791-0C4A5169-1E66-4796-B21E-62C894901E34Q36478221-5A83575A-7C54-4947-8587-1CBA3A82F013Q36480698-5175D51A-1C79-4EF6-A7FB-B4904A5D719C
P2860
ARBITER: Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol: a randomized trial comparing the effects of atorvastatin and pravastatin on carotid intima medial thickness.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
ARBITER: Arterial Biology for ...... rotid intima medial thickness.
@en
ARBITER: Arterial Biology for ...... rotid intima medial thickness.
@nl
type
label
ARBITER: Arterial Biology for ...... rotid intima medial thickness.
@en
ARBITER: Arterial Biology for ...... rotid intima medial thickness.
@nl
prefLabel
ARBITER: Arterial Biology for ...... rotid intima medial thickness.
@en
ARBITER: Arterial Biology for ...... rotid intima medial thickness.
@nl
P2093
P1433
P1476
ARBITER: Arterial Biology for ...... rotid intima medial thickness.
@en
P2093
Allen J Taylor
Louis C Coyle
Marina N Vernalis
Patrick J Flaherty
Steven M Kent
Thor T Markwood
P304
P356
10.1161/01.CIR.0000034508.55617.65
P407
P577
2002-10-01T00:00:00Z